@article{Emelianova_2017,<br/><span class="tab"></span> title={PERSPECTIVES ON USE OF BEVACIZUMAB IN PATIENTS WITH NEUROENDOCRINE TUMORS. CASE REPORT},<br/><span class="tab"></span> volume={16},<br/><span class="tab"></span> ISSN={1814-4861},<br/><span class="tab"></span> url={http://dx.doi.org/10.21294/1814-4861-2017-16-6-100-104},<br/><span class="tab"></span> DOI={10.21294/1814-4861-2017-16-6-100-104},<br/><span class="tab"></span> number={6},<br/><span class="tab"></span> journal={Siberian journal of oncology},<br/><span class="tab"></span> publisher={Tomsk Cancer Research Institute},<br/><span class="tab"></span> author={Emelianova,<br/><span class="tab"></span> G. S. and Orel,<br/><span class="tab"></span> N. F. and Gorbunova,<br/><span class="tab"></span> V. A. and Kolomeytseva,<br/><span class="tab"></span> A. A. and Kuznetsova,<br/><span class="tab"></span> A. A. and Kuzminov,<br/><span class="tab"></span> A. E. and Fedenko,<br/><span class="tab"></span> A. A.},<br/><span class="tab"></span> year={2017},<br/><span class="tab"></span> month=jan,<br/><span class="tab"></span> pages={100–104} }